Bhupal Reddy Auothu

Bhupal Reddy Auothu currently serves as Site Head for Cell and Gene Therapy at Dr. Reddy's Laboratories since March 2024. Prior to this role, Bhupal Reddy held the position of CMC Lead for Cell and Gene Therapy Manufacturing, MSAT, and QC Operations at Autolus Ltd. from June 2023 to March 2024. Bhupal Reddy's experience at GSK spanned seven years with roles including Principal Investigator, Workstream Lead for CMC Cell and Gene Therapy, Investigator for CMC Analytics, and Senior Scientist in Analytical R&D for Cell and Gene Therapy. Earlier career highlights include serving as Lead Scientist at Covance, focusing on CMC Biopharm CRO Operations, and contributing significant expertise in various roles at Serum Institute of India Limited, Wockhardt Ltd., and Shantha Biotechnics Limited. Bhupal Reddy Auothu holds a Master's degree in Bio-Chemistry from Acharya Nagarjuna University, completed between 2000 and 2002.